Abdullah Al Emran

Employment

• Harvard Medical School Research Fellow
  2021 - Present
• Centenary Institute Postdoc
  2018 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (32)

• BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti‐CTLA‐4 treatment
  Pigment Cell & Melanoma Research 2024 DOI: 10.1111/pcmr.13174
  +Save
• Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma
  Journal of Investigative Dermatology 2022 DOI: 10.1016/j.jid.2021.09.028
  +Save
• Nicotinamide Inhibits T Cell Exhaustion and Increases Differentiation of CD8 Effector T Cells
  Cancers 2022 DOI: 10.3390/cancers14020323
  +Save
• Bioinformatics approaches to investigate the phytochemicals of Centella asiatica against the main protease of SARS-CoV-2
  Md. Arif Khan, Md. Abdullah Al Mamun Khan, Shahidur Rahman

  +9 more

  • Asif Ahsan
  • Jannatul Maowa Sanjana
  • Shafi Mahmud
  • A. M. U. B. Mahfuz
  • Ashik Sharfaraz
  • +4 more
  2021 DOI: 10.21203/rs.3.rs-1099054/v1
  +Save
• Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma.
  The Journal of investigative dermatology 2021 DOI: 10.1016/j.jid.2021.09.030
  +Save
• A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma
  Journal of Investigative Dermatology 2021 DOI: 10.1016/j.jid.2020.12.038
  +Save
• Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers.
  Frontiers in genetics 2021 DOI: 10.3389/fgene.2021.680633
  +Save
• DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular Carcinoma
  Cancers 2021 DOI: 10.3390/cancers13071637
  +Save
• Sex bias of females in survival from cancer and infections. Is X the answer?
  British Journal of Cancer 2021 DOI: 10.1038/s41416-020-01245-1
  +Save
• Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?
  Pigment Cell & Melanoma Research 2020 DOI: 10.1111/pcmr.12870
  +Save
• Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
  Cancers 2020 DOI: 10.3390/cancers12082082
  +Save
• EZH2 cooperates with DNA methylation to downregulate key tumour suppressors and interferon gene signatures in melanoma.
  Jessamy C. Tiffen, Stuart J. Gallagher, Fabian V. Filipp +10 more
  The Journal of investigative dermatology 2020 DOI: 10.1016/j.jid.2020.02.042
  +Save
• Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma.
  International journal of cancer 2020 DOI: 10.1002/ijc.33000
  +Save
• Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition.
  International journal of oncology 2020 DOI: 10.3892/ijo.2020.5031
  +Save
• Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients.
  Frontiers in Immunology 2020 DOI: 10.3389/fimmu.2020.00372
  +Save
• Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer.
  Epigenomics 2019 DOI: 10.2217/epi-2018-0173
  +Save
• Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming.
  Clinical epigenetics 2019 DOI: 10.1186/s13148-019-0644-y
  +Save
• Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy.
  Abdullah Al Emran, Aniruddha Chatterjee, Euan James Rodger +4 more
  Trends in immunology 2019 DOI: 10.1016/j.it.2019.02.004
  +Save
• Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma.
  Cancer medicine 2019 DOI: 10.1002/cam4.1978
  +Save
• Distinct epigenetic modifications denote early drug resistance in cancer
  2018 DOI: 10.14264/uql.2018.770
  +Save